The First Sublingual Formulation of Sufentanil
For patients with acute pain severe enough to require an opioid, DSUVIA offers a noninvasive option when opioids are needed in a medically supervised setting.
You're invited to learn more about DSUVIA, the first sublingual formulation of sufentanil. This program will cover the:
For additional information regarding this event, please contact Catherine Alto at 703-217-4178 or firstname.lastname@example.org.
Please register online here: http://www.acelrxprograms.com
Registration Code: 12129SR75
Click here to download the full invitation.
Copyright 2017 - Delaware Association of Nurse Anesthetists (DANA)
Contact Us | Site Map | Site by Merge Creative